Position in AMGN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,567,255
+$150,707 QoQ
Shares Held
4,328
+7.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
#1,416
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 53%
Shared 0%
None 47%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AFFINITY INVESTMENT ADVISORS, LLC holds $11,731,822 across 9 Drug Manufacturers - General names. AMGN ranks #5 (13.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
8,898 | $2,239,092 | |
| 2 | JNJ |
Johnson & Johnson
|
8,462 | $2,149,094 | |
| 3 | PFE |
Pfizer Inc
|
79,689 | $1,918,911 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
30,557 | $1,760,694 | |
| 5 | AMGN |
Amgen Inc
This page
|
4,328 | $1,567,255 | |
| 6 | MRK |
Merck & Co., Inc.
|
7,172 | $921,602 | |
| 7 | LLY |
ELI LILLY & Co
|
360 | $431,794 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,040 | $384,073 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,567,255 | 4,328 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,416,548 | 4,026 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,328,223 | 4,058 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,155,326 | 4,094 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,141,410 | 4,088 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,359,915 | 4,365 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,248,726 | 4,791 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,665,825 | 5,170 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $1,511,633 | 4,838 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,684,027 | 5,923 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,089,003 | 3,781 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $843,100 | 3,137 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $723,119 | 3,257 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,130,423 | 4,676 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $1,227,054 | 4,672 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $1,051,716 | 4,666 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,140,590 | 4,688 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $1,181,290 | 4,885 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $1,124,850 | 5,000 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $1,090,894 | 5,130 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $1,258,968 | 5,165 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $4,034,702 | 16,216 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $3,770,228 | 16,398 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $4,371,297 | 17,199 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $4,362,938 | 18,498 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $4,634,813 | 22,862 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||